Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 10th December 2019
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

EMA issues advice for users of live PRRS vaccines
The VMD has been made aware of an incident in Denmark involving an outbreak or PRRS.
Recent outbreak resulted from the recombination of vaccine strains from two live PRRS vaccines

The European Medicines Agency (EMA) has produced some advice for users of live Porcine Reproductive and Respiratory Syndrome (PRRS) vaccines following an ‘incident’ in Denmark.

The Veterinary Medicines Directorate (VMD) said in a statement that it ‘has been made aware of an incident in Denmark involving an outbreak of PRRS.

‘This outbreak has been caused by an emergent recombinant strain of PRRS virus which is believed to have resulted from the recombination of vaccine strains from two live PRRS vaccines which had both been used on the farm.’

The statement continued: ‘Further investigation is ongoing. Whilst waiting for further information the European Medicines Agency (EMA) has produced some advice for all users of live PRRS vaccines. The advice is contained in the last item in the EMA’s press release.’

The VMD is reminding users to report any cases of adverse reactions or suspected lack of efficacy involving these vaccines to the relevant marketing authorisation holder or direct to the VMD via its online reporting form.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.